Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998050019) STABLE ORAL PHARMACEUTICAL DOSAGE FORMS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/050019 International Application No.: PCT/US1998/009449
Publication Date: 12.11.1998 International Filing Date: 08.05.1998
Chapter 2 Demand Filed: 19.11.1998
IPC:
A61K 9/28 (2006.01) ,A61K 9/48 (2006.01) ,A61K 31/4184 (2006.01) ,A61K 31/4439 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
28
Dragees; Coated pills or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4184
condensed with carbocyclic rings, e.g. benzimidazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4427
containing further heterocyclic ring systems
4439
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Applicants:
SAGE PHARMACEUTICALS, INC. [US/US]; 5408 Interstate Avenue Shreveport, LA 71109, US (AllExceptUS)
CHEN, Jivn-Ren [US/US]; US (UsOnly)
Inventors:
CHEN, Jivn-Ren; US
Agent:
CHAN, Albert, Wai-Kit; Cooper & Dunham LLP 1185 Avenue of the Americas New York, NY 10036, US
Priority Data:
08/950,43215.10.1997US
60/046,08909.05.1997US
Title (EN) STABLE ORAL PHARMACEUTICAL DOSAGE FORMS
(FR) FORMES POSOLOGIQUES PHARMACEUTIQUES ORALES STABLES
Abstract:
(EN) The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such a dosage form, and to a method of gastric acid pump inhibition and providing gastrointestinal cytoprotective benefit by using them.
(FR) La présente invention concerne de nouvelles formes posologiques pharmaceutiques entériques stables, destinées à être utilisées par voie orale, et renfermant de l'Omeprazole ou du Lansoprazole. Cette invention concerne également une formulation et un procédé de fabrication de ces formes posologiques, ainsi qu'un procédé d'inhibition de la pompe à suc gastrique, l'utilisation de cette formulation et de ces procédés produisant un effet gastro-intestinal cytoprotecteur.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
KR1020010012402US20030203018JP2001524131 AU1998073755